Thromb Haemost 1998; 80(04): 712-713
DOI: 10.1055/s-0037-1615453
Letters to the Editor
Schattauer GmbH

Variability of Soluble Tissue Factor in Primary Antiphospholipid Syndrome

María J. Cuadrado
1   From Rheumatology and Haematology Department Hospital Universitario “Reina Sofía” Córdoba, and Hospital Regional “Carlos Haya”, Málaga, Spain
,
Pablo M. Dobado-Berrios
1   From Rheumatology and Haematology Department Hospital Universitario “Reina Sofía” Córdoba, and Hospital Regional “Carlos Haya”, Málaga, Spain
,
Chary López-Pedrera
1   From Rheumatology and Haematology Department Hospital Universitario “Reina Sofía” Córdoba, and Hospital Regional “Carlos Haya”, Málaga, Spain
,
Juan M. Gómez-Zumaquero
1   From Rheumatology and Haematology Department Hospital Universitario “Reina Sofía” Córdoba, and Hospital Regional “Carlos Haya”, Málaga, Spain
,
Francisco Tinahones
1   From Rheumatology and Haematology Department Hospital Universitario “Reina Sofía” Córdoba, and Hospital Regional “Carlos Haya”, Málaga, Spain
,
Ana Jurado
1   From Rheumatology and Haematology Department Hospital Universitario “Reina Sofía” Córdoba, and Hospital Regional “Carlos Haya”, Málaga, Spain
,
Teresa Camps
1   From Rheumatology and Haematology Department Hospital Universitario “Reina Sofía” Córdoba, and Hospital Regional “Carlos Haya”, Málaga, Spain
,
Antonio Torres
1   From Rheumatology and Haematology Department Hospital Universitario “Reina Sofía” Córdoba, and Hospital Regional “Carlos Haya”, Málaga, Spain
,
Francisco Velasco
1   From Rheumatology and Haematology Department Hospital Universitario “Reina Sofía” Córdoba, and Hospital Regional “Carlos Haya”, Málaga, Spain
› Author Affiliations
Further Information

Publication History

Received 10 March 1998

Accepted after resubmission 05 June 1998

Publication Date:
08 December 2017 (online)

 

 
  • References

  • 1 Hughes GRV. The antiphospholipid syndrome: ten years on.. Lancet 1993; 342: 342-4.
  • 2 Cuadrado MJ, Lopez-Pedrera Ch, Khamashta MA. et al. Thrombosis in primary antiphospholipid syndrome: A pivotal role for monocyte tissue factor expression.. Arthritis and Rheum 1998; 40: 834-41.
  • 3 Kornberg A, Blank M, Kaufman S, Shoenfeld Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies.. J Immunol 1994; 153: 1328-32.
  • 4 Atsumi Khamashta MA, Amengual O, Hughes GRV. Up-regulated tissue factor expression in antiphospholipid syndrome.. Thromb Haemost 1998; 77: 212-3.
  • 5 Harris EN, Baguley R, Asherson RA, Hughes GRV. Clinical and serological features of the antiphospholipid syndrome (APS).. Br J Rheumatol 1987; 26 (Suppl. 02) 19 (abstract)
  • 6 Tinahones F, Cuadrado MJ, Gomez-Zumaquero JM, Camps MT, Mujic F, Khamashta MA, Hughes GRV. Lack of crossreaction between anti-β2 glycoprotein I and anti-oxidized low density lipoproteins antibodies.. Br J Rheumtol 1998 (in press).
  • 7 Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.. Arterioscler Thromb Vasc Biol 1996; 16: 1170-6.
  • 8 Luscher TF, Barton M. Biology of the endothelium.. Clin Cardiol 1998; 20 11 Suppl 2 310-7.
  • 9 Panza JA. Endothelial dysfunction in essential hypertension.. Clin Cardiol 1998; 20 11 Suppl 2 2633-8.
  • 10 Lominadze D, Joshua IG, Schuschke DA. In vivo platelet thrombus formation in microvessels of spontaneously hypertensive rats.. Am J Hypertens 1998; 10: 1140-6.